SERA News and Press, Sera Prognostics Inc. From 05/02/22

Sera Prognostics Announces Conference Call and Webcast of First Quarter Fiscal Year 2022 Financial Results on May 10 PR Newswire SALT LAKE CITY , May 2, 2022 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focuse...

SERA PROGNOSTICS ANNOUNCES THE APPOINTMENT OF DR. JANE F. BARLOW TO THE SERA PROGNOSTICS BOARD PR Newswire - Accomplished business and health services leader joins Sera in its quest to improve pregnancy outcomes of mothers and babies - SALT LAKE CITY ...

Citi has downgraded diagnostics company Sera Prognostics (SERA -7.7%) to neutral from buy following what it called disappointing Q4 2021 results and fiscal year 2022 revenue guidance. The firm also cut its target price to $4 from $18 (~1% downside based on Tuesday's close). Analyst Patrick Do...

Image source: The Motley Fool. Sera Prognostics, Inc. (NASDAQ: SERA) Q4 2021 Earnings Call Mar 29, 2022 , 5:00 p.m. ET Operator Continue reading For further details see: Sera Prognostics, Inc. (SERA) Q4 2021 Earnings Call Transcript

Sera Prognostics, Inc. (SERA) Q4 2021 Earnings Conference Call March 29, 2022 05:00 PM ET Company Participants Peter DeNardo - IR Gregory Critchfield - Chairman, President, and CEO Jay Moyes - CFO Conference Call Participants Patrick Donnelly - Citi Dustin Scaringe - William Blair Kevin DeGee...

Sera Prognostics press release (NASDAQ:SERA): Q4 GAAP EPS of -$0.41. Revenue of $26K (+333.3% Y/Y). For further details see: Sera Prognostics GAAP EPS of -$0.41, revenue of $26K

SERA PROGNOSTICS REPORTS FOURTH QUARTER 2021 FINANCIAL RESULTS PR Newswire SALT LAKE CITY , March 29, 2022 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by ...

Gainers: NeuroSense Therapeutics (NRSN) +289%. Yumanity Therapeutics (YMTX) +36%. Dermata Therapeutics (SERA) +30%. Sera Prognostics (DRMA) +21%. Creative Medical Technology Holdings (CELZ) +20%. Losers: Vallon Pharmaceuticals (VLON) -70%. Connect Biopharma Holdings (CNTB) -22%. Imm...

Gainers: Sera Prognostics (SERA) +10%. Harte-Hanks  (HHS) +7%. Precigen (PGEN) +5%. Greenidge Generation Holdings  (GREE) +5%. IGM Biosciences (IGMS) +5%. Losers: Connect Biopharma Holdings Limited (CNTB) -17%. Arhaus (ARHS) -5%. Fluent (FLNT) -5%. Marinus Pharmaceuticals ...

Sera Prognostics Presents Data Demonstrating Prediction of Preeclampsia Utilizing Protein Biomarker and Clinical Factors at SRI Annual Meeting PR Newswire SALT LAKE CITY , March 18, 2022 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company...